XLV Bears Rebuild Briefly, Then Retreat Again

XLV is caught between two competing forces this week: a brief short rebuilding attempt that has already started to reverse, and options positioning that remains persistently defensive.

The short cover story that dominated last week's note has taken a detour. Short interest climbed 8.7% over the past week to reach 6.2% of free float, reversing the multi-week unwind that had pushed SI down more than 16% from its early-October peak. That looks like a fresh tactical short being put on, not a capitulation of the covering trend. But then on Tuesday alone, SI dropped 6.9% in a single session, back down to 16.0 million shares. The week-on-week rise therefore reflects an intraweek spike that is already dissipating rather than a sustained new short campaign.

The borrow market has moved in the same direction. Cost to borrow has continued to fall, now at 0.55%, down 15% on the week and nearly 39% over the past month, reflecting the same softening conviction among bears that last week's note described. Availability tells the more volatile story: it swung from just 25% of outstanding short interest on Monday to 109% by Tuesday, a dramatic single-day release of supply. That kind of intraday availability whipsaw is unusual and points to a large position being restructured rather than a smooth market. The 52-week availability low was 3.4%, touched on October 1 when the borrow pool was essentially fully lent; the current reading of 109% represents the other extreme of a journey that has happened in under four weeks.

Options positioning has not shifted to match the short covering. The put/call ratio is 1.72, sitting just shy of its 20-day average of 1.68 and well within one standard deviation of normal, but the absolute level remains elevated relative to the past year's range of 0.47 to 2.67. Healthcare sector funds tend to carry structurally higher put/call ratios as portfolio hedges, and XLV is no exception. What is notable is that the ratio has barely moved across a month when the stock gained nearly 5% and shorts covered aggressively. Options buyers have not given up their defensive positioning despite the price recovery. The ORTEX short score has eased slightly from around 59 last Monday to 55.7 by Tuesday, consistent with a positioning environment that is cautious but not extreme.

The institutional register reflects a split picture. As of the June 30 filing period, Managed Account Advisors, the largest reported holder, added 914,873 shares to reach 9% of the fund. Goldman Sachs added 1.3 million shares. JPMorgan cut its position by 2.7 million shares, the largest reduction among the top holders. Envestnet trimmed by 934,000 shares. Taken together, the broker-dealer community was net sellers while advisory accounts added. That divergence is worth watching as the October 31 quarter-end filings approach.

The price itself has given back a small amount of the prior week's gains. XLV closed at $179.18, down less than 0.1% on the day and off 0.4% on the week, after climbing nearly 5% over the past month. The next meaningful read on sentiment will be whether the brief short rebuild that appeared mid-week hardens into a renewed bear campaign or continues to deflate alongside the borrow cost.